SMYD3 impedes small cell lung cancer sensitivity to alkylation damage through RNF113A methylation-phosphorylation cross-talk

Authors

Valentina Lukinović, Grenoble Alpes University
Clement Oyeniran, Washington University School of Medicine in St. Louis
Ning Tsao, Washington University School of Medicine in St. Louis
Joshua R Brickner, Washington University School of Medicine in St. Louis
Rebecca Rodell, Washington University School of Medicine in St. Louis
Nima Mosammaparast, Washington University School of Medicine in St. Louis
Et al

Journal

Cancer Discovery

Publication Date

9-2-2022

Volume

12

Issue

9

First Page

2158

Last Page

2179

Document Type

Open Access Publication

DOI

10.1158/2159-8290.CD-21-0205

Rights and Permissions

Lukinović V, Hausmann S, Roth GS, Oyeniran C, Ahmad T, Tsao N, Brickner JR, Casanova AG, Chuffart F, Benitez AM, Vayr J, Rodell R, Tardif M, Jansen PWTC, Couté Y, Vermeulen M, Hainaut P, Mazur PK, Mosammaparast N, Reynoird N. SMYD3 Impedes Small Cell Lung Cancer Sensitivity to Alkylation Damage through RNF113A Methylation-Phosphorylation Cross-talk. Cancer Discov. 2022 Sep 2;12(9):2158-2179. doi: 10.1158/2159-8290.CD-21-0205 This work is licensed under a Creative Commons Attribution 4.0 International License.

Recommended Citation

Lukinović, Valentina; Oyeniran, Clement; Tsao, Ning; Brickner, Joshua R; Rodell, Rebecca; Mosammaparast, Nima; and Et al, "SMYD3 impedes small cell lung cancer sensitivity to alkylation damage through RNF113A methylation-phosphorylation cross-talk." Cancer Discovery. 12, 9. 2158 - 2179. (2022).
https://digitalcommons.wustl.edu/oa_4/412